EI

260.4

-0.08%↓

SAN

80.44

+2.35%↑

MRK1

110.65

+0.23%↑

SHL.DE

47.2

+0.11%↑

ARGX

645.6

+0.31%↑

EI

260.4

-0.08%↓

SAN

80.44

+2.35%↑

MRK1

110.65

+0.23%↑

SHL.DE

47.2

+0.11%↑

ARGX

645.6

+0.31%↑

EI

260.4

-0.08%↓

SAN

80.44

+2.35%↑

MRK1

110.65

+0.23%↑

SHL.DE

47.2

+0.11%↑

ARGX

645.6

+0.31%↑

EI

260.4

-0.08%↓

SAN

80.44

+2.35%↑

MRK1

110.65

+0.23%↑

SHL.DE

47.2

+0.11%↑

ARGX

645.6

+0.31%↑

EI

260.4

-0.08%↓

SAN

80.44

+2.35%↑

MRK1

110.65

+0.23%↑

SHL.DE

47.2

+0.11%↑

ARGX

645.6

+0.31%↑

Search

Orion Oyj (Class B)

Atvērts

65.75 0.38

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

64.95

Max

65.9

Galvenie mērījumi

By Trading Economics

Ienākumi

119M

180M

Pārdošana

62M

417M

P/E

Sektora vidējais

25.093

35.733

EPS

0.59

Dividenžu ienesīgums

2.4

Peļņas marža

43.289

Darbinieki

3,700

EBITDA

202M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

2.40%

3.13%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

609M

9.5B

Iepriekšējā atvēršanas cena

65.37

Iepriekšējā slēgšanas cena

65.75

Orion Oyj (Class B) Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 8. sept. 23:59 UTC

Iegādes, apvienošanās, pārņemšana

Anglo American Is in Talks to Buy Teck Resources, Bloomberg Says

2025. g. 8. sept. 22:02 UTC

Galvenie tirgus virzītāji

Microsoft Signs $17.4 Billion AI Deal With Nebius

2025. g. 8. sept. 17:01 UTC

Galvenie tirgus virzītāji

Eightco Holdings Stock Surges as Dan Ives Joins Board Amid Crypto Push

2025. g. 8. sept. 17:01 UTC

Galvenie tirgus virzītāji

Tron Shares Rise After New Investment From Bravemorning

2025. g. 8. sept. 16:14 UTC

Galvenie tirgus virzītāji

Beyond Air Shares Climb on FDA Orphan Drug Designation for Brain Cancer Treatment

2025. g. 8. sept. 16:13 UTC

Galvenie tirgus virzītāji

Dianthus Shares Whipsaw on Strong Trial Results, Safety Concerns

2025. g. 8. sept. 23:12 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 8. sept. 23:12 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 8. sept. 23:12 UTC

Tirgus saruna

Infratil's New Bull Likes Exposure to Growing Infrastructure Businesses -- Market Talk

2025. g. 8. sept. 22:56 UTC

Tirgus saruna

Worst May Be Over for New Zealand Retailers -- Market Talk

2025. g. 8. sept. 22:23 UTC

Tirgus saruna

Ebos's Near-Term Earnings Outlook Dims -- Market Talk

2025. g. 8. sept. 21:51 UTC

Tirgus saruna

AT&T Backs Outlook After EchoStar Spectrum Purchase -- Market Talk

2025. g. 8. sept. 21:47 UTC

Galvenie tirgus virzītāji

Microsoft Signs $17.4B AI Deal With Nebius

2025. g. 8. sept. 21:33 UTC

Iegādes, apvienošanās, pārņemšana

This Quantum Pure Play Is Going Public. What Infleqtion Does Differently, Says Its CEO. -- Barrons.com

2025. g. 8. sept. 21:20 UTC

Iegādes, apvienošanās, pārņemšana

MEG Energy Plans to Respond on or Before Sept 15 >MEG.T

2025. g. 8. sept. 21:19 UTC

Iegādes, apvienošanās, pārņemšana

MEG Energy Special Committee and Board Will Evaluate Revised Strathcona Offer >MEG.T

2025. g. 8. sept. 21:18 UTC

Iegādes, apvienošanās, pārņemšana

MEG Energy Acknowledges Strathcona's Intention to Revise Offer

2025. g. 8. sept. 20:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2025. g. 8. sept. 19:33 UTC

Tirgus saruna

Oil Futures Gain Despite Planned OPEC+ Output Increases -- Market Talk

2025. g. 8. sept. 19:22 UTC

Tirgus saruna

U.S. Natural Gas Futures Settle Higher -- Market Talk

2025. g. 8. sept. 19:02 UTC

Tirgus saruna

Dollar Lukewarm Amid Data Hiatus Ahead of August CPI -- Market Talk

2025. g. 8. sept. 18:24 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 8. sept. 18:24 UTC

Tirgus saruna

Weaker Argentine Peso Profitable for Grain Producers -- Market Talk

2025. g. 8. sept. 17:29 UTC

Tirgus saruna

Mexican Inflation Seen Little Changed in August -- Market Talk

2025. g. 8. sept. 16:59 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

SpaceX Spectrum Acquisition Will Create More Satellite Connection Supply, Verizon CEO Says -- Market Talk

2025. g. 8. sept. 16:36 UTC

Tirgus saruna

Crude Futures Hold Gains After OPEC+ Output Decision -- Market Talk

2025. g. 8. sept. 16:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 8. sept. 16:16 UTC

Peļņas

Strategy Stock May Not Ever Make It Into the S&P 500 Index -- Barrons.com

2025. g. 8. sept. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 8. sept. 16:04 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Orion Oyj (Class B) Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
help-icon Live chat